arylid has been researched along with niclosamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Barak, LS; Chen, M; Chen, W; Lyerly, HK; Mook, RA; Ren, XR; Spasojevic, I; Wang, J | 1 |
Chen, CZ; Chen, L; Eastman, RT; Guo, H; Hu, X; Huang, R; Huang, W; Itkin, Z; Klumpp-Thomas, C; Lee, EM; Lo, DC; Lu, X; Michael, S; Ming, GL; Shah, P; Shamim, K; Shen, M; Shinn, P; Simeonov, A; Song, H; Tang, H; Xu, M; Xu, X; Zheng, W | 1 |
2 other study(ies) available for arylid and niclosamide
Article | Year |
---|---|
Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure.
Topics: beta Catenin; Cell Line, Tumor; Cell Proliferation; Humans; Niclosamide; Structure-Activity Relationship; Wnt Proteins; Wnt Signaling Pathway | 2015 |
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection.
Topics: Animals; Antiviral Agents; Binding Sites; Chlorocebus aethiops; Drug Stability; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Niclosamide; Protein Binding; Rats; SARS-CoV-2; Serine Endopeptidases; Structure-Activity Relationship; Vero Cells; Viral Nonstructural Proteins; Viral Proteins; Zika Virus | 2021 |